Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes

Hepatology

Volumn 46, Issue 3, 2007, Pages 823-830

  Joshi Barve, Swati ^a   Barve, Shirish S ^a   Amancherla, Kiranmayi ^a   Gobejishvili, Leila ^a   Hill, Daniell ^a   Cave, Matthew ^a   Hote, Prachi ^a   McClain, Craig J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PALMITIC ACID; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATTY LIVER; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID STORAGE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

CELL LINE, TUMOR; CHEMOKINES, CXC; CYTOKINES; FATTY LIVER; HEPATOCYTES; HUMANS; INTERLEUKIN-8; LIPIDS; MAP KINASE KINASE 4; NF-KAPPA B; PALMITIC ACID; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRIGLYCERIDES;

EID: 34548746833     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21752     Document Type: Article

References (36)

1. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. J Clin Invest 2002;32(Suppl 3):14-23.
2. Neuschwander-Tetri B. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 2005;330:326-335.
3. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006;40(Suppl 1):S17-S29.
4. Day CP, James OF. Steatohepatitis: a tale of two hits? Gastroenterology 1998;114:842-845.
5. Remick DG. Interleukin-8. Crit Care Med 2005;33(12 Suppl):S466-S467.
6. Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 2006; 30:1347-1355.
7. Jaeschke H, Mullen KD, Moradpour D. Comments. Inflammation in response to hepatocellular apoptosis. HEPATOLOGY 2002;35:964-965.
8. Hill DB, Marsano L, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. HEPATOLOGY 1993;18:576-580.
9. Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ. Inhibition of proteasome function leads to NF-κB-independent IL-8 expression in human hepatocytes. HEPATOLOGY 2003;38:1178-1187.
10. Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 1990;144:2609-2613.
11. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. HEPATOLOGY 2003;38:413-419.
12. Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, Seckin D, et al. Levels of serum hyaluronic acid, TNF-α and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology 2005;52:1549-1553.
13. Lee JG, Calcalano TC, Camerato KT, Moore MW, Wood WI. Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol 1995;155:2158-2164.
14. Deaciuc IV, Alappat JM, D'Souza NB, Van Thiel DH, McClain CJ. Tumor necrosis factor-alpha internalization and degradation by isolated hepatocytes of rats exposed to ethanol. Alcohol 1998;16:125-133.
15. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001;276:14890-14895.
16. Fraser DA, Thoen J, Rustan AC, Forre O, Kjeldsen-Kragh J. Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects on T lymphocyte proliferarion. Rheumatology (Oxford) 1999;38:948-952.
17. Nakamura T, Azuma A, Kuribayashi T, Sugihara H, Okuda S, Nakagawa M. Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: the Kumihama study. Br J Nutr 2003;89: 267-272.
18. Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK dependent hepatocyte lipoapoptosis. J Biol Chem 2006;281:12093-12101.
19. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.
20. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
21. Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 2001;46:2347-2352.
22. Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med 2006;6:19-25.
23. McClain CJ, Mokshagundam SP, Barve SS, Song Z, Hill DB, Chen T, et al. Mechanisms of non-alcoholic steatohepatitis. Alcohol 2004;34:67-79.
24. Jove M, Planavila A, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M. Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 2006;147:552-561.
25. Ajuwon KM, Spurlock ME. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 2005;135:1841-1846.
26. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. HEPATOLOGY 2004;40:185-194.
27. Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006;30:1197-1202.
28. Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I. Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol 2003;16:2-5.
29. Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin- and Fas-antibody- mediated liver injury. HEPATOLOGY 1998;28:761-767.
30. Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D. Micrococci and peptidoglycan activate TLR2->MyD88->IRAK->TRAF->NIK->IKK->NF- kappaB signal transduction pathway that induces transcription of intetleukin-8. Infect Immun 2001;69:2270-2276.
31. Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D. Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol. 2000;165:3384-3392.
32. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420: 333-336.
33. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. HEPATOLOGY 2006;43:163-172.
34. Schuchmann M, Galle PR. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001;13:785-790.
35. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-443.
36. Zoli M, Tepper M, Lohez M, Arcangeli G, Ganne N, Christidis C, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001;34:254-260.